Evaluation of Zonulin Levels, Trimethylamine-N-oxide, Indoxyl Sulphate and P-Cresol Sulphate Levels in Patients with Hashimoto's Thyroiditis
Project no. 32527 · Status: Kapanmış (Yayın bekleniyor) · 2024
Summary
<p>Hashimoto's thyroiditis (HT) is a common autoimmune disorder that affects women 7-10 times more frequently than men. It develops due to inactivation regions on the X chromosome, which are modulated by genetic susceptibility, environmental factors, and microbiome composition, leading to an imbalance in self-tolerance mechanisms. Patients require hormone replacement with oral levothyroxine, and if left untreated, it can have serious adverse effects on health and ultimately lead to death. As intestinal permeability is an issue in HT patients, the composition and abundance of the gut microbiota also show marked differences. This phenomenon led us to consider whether the gut microbiota could influence the progression of HT via permeability. It has been demonstrated in the literature that metabolites derived from the gut microbiota, such as uremic toxins (Trimethylamine-N-oxide (TMAO), indoxyl sulphate, and P-cresol sulphate), contribute to the progression of cardiovascular diseases associated with increased intestinal permeability. However, their effect on autoimmune diseases is unclear. A systematic and detailed study showing how HT patients are affected has not yet been conducted. The aim of the study is to examine zonulin protein levels to determine intestinal permeability in patients, to determine the levels of uremic toxins that increase as a result of this permeability, and to investigate their relationship with the disease.The study will include two groups: HT patients and healthy controls. Zonulin protein levels will be measured using the ELISA method, while trimethylamine-N-oxide (TMAO), indoxyl sulphate and p-cresol sulphate levels will be measured using the LC/MS-MS method. This study was supported by the <strong>Ege University Research and Research Unit. </strong></p><p></p><p>The unique aspect of the proposed project is that (i) the effect of increased levels of uremic toxins (Trimethylamine-N-oxide (TMAO), indoxyl sulfate and P-cresol sulfate) due to increased intestinal permeability in hypertensive patients on the disease is investigated for the first time, and (ii) the response in these parameters is evaluated by comparing it with the healthy group.</p>